Efficacy and Safety of Fibrinogen Concentrate in Surgical Patients: A Meta-Analysis of Randomized Controlled Trials

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 30, Issue 5, 2016, Pages 1196-1204

  Fominskiy, Evgeny ^a,b   Nepomniashchikh, Valeriy A ^a   Lomivorotov, Vladimir V ^b   Monaco, Fabrizio ^a   Vitiello, Chiara ^a   Zangrillo, Alberto ^a,c   Landoni, Giovanni ^a,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b MESHALKIN NATIONAL MEDICAL RESEARCH CENTER   (Russian Federation)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

efficacy; fibrinogen; hemorrhage; safety; surgery

Indexed keywords

FIBRINOGEN CONCENTRATE; PLACEBO; FIBRINOGEN;

ARTICLE; BLEEDING; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; HEART INFARCTION; HEART SURGERY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURGICAL MORTALITY; SURGICAL PATIENT; SYSTEMATIC REVIEW; THROMBOSIS; PERIOPERATIVE PERIOD; PROCEDURES; SURGERY; TREATMENT OUTCOME;

FIBRINOGEN; HUMANS; PERIOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME;

EID: 84991101935     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2016.04.015     Document Type: Article

References (47)

1. 1 Corral, M., Ferko, N., Hollmann, S., et al. Health and economic outcomes associated with uncontrolled surgical bleeding: A retrospective analysis of the Premier Perspectives Database. Clinicoecon Outcomes Res 7 (2015), 409–421.
2. 2 Bolliger, D., Gorlinger, K., Tanaka, K.A., Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 113 (2010), 1205–1219.
3. 3 Goodnough, L.T., Levy, J.H., Murphy, M.F., Concepts of blood transfusion in adults. Lancet 381 (2013), 1845–1854.
4. 4 Marik, P.E., Corwin, H.L., Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature. Crit Care Med 36 (2008), 2667–2674.
5. 5 Kozek-Langenecker, S., Sørensen, B., Hess, J.R., et al. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: A systematic review. Crit Care, 15, 2011, R239.
6. 6 Mosesson, M.W., Fibrinogen and fibrin structure and functions. J Thromb Haemost 3 (2005), 1894–1904.
7. 7 Wikkelsø, A., Lunde, J., Johansen, M., et al. Fibrinogen concentrate in bleeding patients. Cochrane Database Syst Rev, 8, 2013, CD008864.
8. 8 Lunde, J., Stensballe, J., Wikkelsø, A., et al. Fibrinogen concentrate for bleeding-a systematic review. Acta Anaesthesiol Scand 58 (2014), 1061–1074.
9. 9 [No authors listed]: Practice guidelines for perioperative blood management. An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology 122 (2015), 241–275.
10. 10 Kozek-Langenecker, S.A., Afshari, A., Albaladejo, P., et al. Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 30 (2013), 270–382.
11. 11 Higgins JPT, Green S, eds: Cochrane handbook for systematic reviews of interventions, version 5.1.0. Available at: 〈www.cochrane-handbook.org〉. Accessed April 27, 2016.
12. 12 Cui, Y., Hei, F., Long, C., et al. Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. Artif Organs 34 (2010), 955–960.
13. 13 Fenger-Eriksen, C., Jensen, T.M., Kristensen, B.S., et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: A randomized, placebo-controlled clinical trial. J Thromb Haemost 7 (2009), 795–802.
14. 14 Galas, F.R., de Almeida, J.P., Fukushima, J.T., et al. Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: A randomized pilot trial. J Thorac Cardiovasc Surg 148 (2014), 1647–1655.
15. 15 Jeppsson, A., Waldén, K., Roman-Emanuel, C., et al. Preoperative supplementation with fibrinogen concentrate in cardiac surgery: A randomized controlled study. Br J Anaesth 116 (2016), 208–214.
16. 16 Karlsson, M., Ternström, L., Hyllner, M., et al. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost 102 (2009), 137–144.
17. 17 Lancé, M.D., Ninivaggi, M., Schols, S.E., et al. Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: A prospective randomized intervention trial. Vox Sang 103 (2012), 25–34.
18. 18 Najafi, A., Shariat Moharari, R., Orandi, A.A., et al. Prophylactic administration of fibrinogen concentrate in perioperative period of total hip arthroplasty: A randomized clinical trial study. Acta Med Iran 52 (2014), 804–810.
19. 19 Rahe-Meyer, N., Solomon, C., Hanke, A., et al. Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: A randomized, placebo-controlled trial. Anesthesiology 118 (2013), 40–50.
20. 20 Rahe-Meyer N: Oral presentation during 2015 year Annual Congress of the European Society of Anaesthesiology, Berlin, May 30-June 2, 2015.
21. 21 Ranucci, M., Baryshnikova, E., Crapelli, G.B., et al. Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. J Am Heart Assoc, 4, 2015, e002066.
22. 22 Sabate A, Gutierrez R, Beltran J, et al: Impact of pre-emptive fibrinogen concentrate on transfusion requirements in liver transplantation: A multicenter, randomized, double-blind, placebo-controlled trial. Am J Transplant 2016 Feb 16. [Epub ahead of print].
23. 23 Sadeghi, M., Atefyekta, R., Azimaraghi, O., et al. A randomized, double blind trial of prophylactic fibrinogen to reduce bleeding in cardiac surgery. Braz J Anesthesiol 64 (2014), 253–257.
24. 24 Tanaka, K.A., Egan, K., Szlam, F., et al. Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: Preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion. Transfusion 54 (2014), 109–118.
25. 25 Wikkelsø, A.J., Edwards, H.M., Afshari, A., et al. Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: Randomized controlled trial. Br J Anaesth 114 (2015), 623–633.
26. 26 Ponschab, M., Landoni, G., Biondi-Zoccai, G., et al. Recombinant activated factor VII increases stroke in cardiac surgery: A meta-analysis. J Cardiothorac Vasc Anesth 25 (2011), 804–810.
27. 27 Fergusson, D.A., Hébert, P.C., Mazer, C.D., et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358 (2008), 2319–2331.
28. 28 Guzzetta, N.A., Allen, N.N., Wilson, E.C., et al. Excessive postoperative bleeding and outcomes in neonates undergoing cardiopulmonary bypass. Anesth Analg 120 (2015), 405–410.
29. 29 Levy, J.H., Dutton, R.P., Hemphill, J.C. 3rd, et al. Multidisciplinary approach to the challenge of hemostasis. Anesth Analg 110 (2010), 354–364.
30. 30 Parekh, A.K., Barton, M.B., The challenge of multiple comorbidity for the US health care system. JAMA 303 (2010), 1303–1304.
31. 31 Ranucci, M., Baryshnikova, E., Simeone, F., et al. Moderate-degree acidosis is an independent determinant of postoperative bleeding in cardiac surgery. Minerva Anestesiol 81 (2015), 885–893.
32. 32 Ranucci, M., Hemostatic and thrombotic issues in cardiac surgery. Semin Thromb Hemost 41 (2015), 84–90.
33. 33 Hiippala, S.T., Myllyla, G.J., Vahtera, E.M., Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 81 (1995), 360–365.
34. 34 Fenger-Eriksen, C., Lindberg-Larsen, M., Christensen, A.Q., et al. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 101 (2008), 769–773.
35. 35 Fenger-Eriksen, C., Ingerslev, J., Sørensen, B., Fibrinogen concentrate—a potential universal hemostatic agent. Expert Opin Biol Ther 9 (2009), 1325–1333.
36. 36 CSL Behring. RiaSTAP prescribing information. Available at: 〈http://labeling.cslbehring.com/PI/US/RiaSTAP/EN/RiaSTAP-Prescribing-Information.pdf〉. Accessed 1 November 1, 2015.
37. 37 Solomon, C., Pichlmaier, U., Schoechl, H., et al. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth 104 (2010), 555–562.
38. 38 Costa-Filho, R., Hochleitner, G., Wendt, M., et al. Over 50 years of fibrinogen concentrate. Clin Appl Thromb Hemost 22 (2016), 109–114.
39. 39 Manco-Johnson, M.J., Dimichele, D., Castaman, G., et al. Pharmacokinetics and safety of fibrinogen concentrate. J Thromb Haemost 7 (2009), 2064–2069.
40. 40 Waldén, K., Jeppsson, A., Nasic, S., et al. Low preoperative fibrinogen plasma concentration is associated with excessive bleeding after cardiac operations. Ann Thorac Surg 97 (2014), 1199–1206.
41. 41 Kindo, M., Hoang Minh, T., Gerelli, S., et al. Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass. Thromb Res 134 (2014), 360–368.
42. 42 Gielen, C., Dekkers, O., Stijnen, T., et al. The effects of pre- and postoperative fibrinogen levels on blood loss after cardiac surgery: A systematic review and meta-analysis. Interact Cardiovasc Thorac Surg 18 (2014), 292–298.
43. 43 Velik-Salchner, C., Haas, T., Innerhofer, P., et al. The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost 5 (2007), 1019–1025.
44. 44 Lang, T., Johanning, K., Metzler, H., et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 108 (2009), 751–758.
45. 45 Aubron, C., Reade, M.C., Fraser, J.F., et al. Efficacy and safety of fibrinogen concentrate in trauma patients—a systematic review. J Crit Care, 29, 2014 471.e11-17.
46. 46 Fassl, J., Lurati Buse, G., Filipovic, M., et al. Perioperative administration of fibrinogen does not increase adverse cardiac and thromboembolic events after cardiac surgery. Br J Anaesth 114 (2015), 225–234.
47. 47 Solomon, C., Gröner, A., Ye, J., et al. Safety of fibrinogen concentrate: Analysis of more than 27 years of pharmacovigilance data. Thromb Haemost 113 (2015), 759–771.